Humaira Shamim, Mahwash Rana, Sumaira Hanif, Nadia Sultan.
Comparison of efficacy of methotrexate and azathioprine in chronic resistant atopic eczema.
J Pak Assoc Derma Jan ;33(3):1057-61.

Background Atopic dermatitis is a common dermatological problem in children and adults. It is associated with poor quality of life, significant financial burdens, and poor mental health. There are many topical and systemic treatment modalities for chronic atopic eczema. Systemic treatment like Methotrexate and azathioprine is indicated in chronic atopic eczema patients resistant to topical steroids.   Objective:  To assess the efficiency of methotrexate versus azathioprine in chronic resistant eczema.   Methods: This study was conducted in the Department of Dermatology in Nishtar Hospital, Multan from January 2012 to July 2012.  270 patients with clinically resistant atopic eczema were included and detailed history and examinations were done. 135 patients were given weekly oral methotrexate and 135 were given oral azathioprine weekly. Patients were followed up for 12 weeks. All data were recorded in a predesigned proforma.   Results: MTX treated group showed statistically significant better efficacy of (51%) when compared to AZA (36%) at 12 weeks.   Conclusion: Methotrexate is more efficacious compared to azathioprine for the treatment of patients with chronic resistant atopic eczema.  

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com